Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Amphotericin B liposomal 50mg powder for dispersion for infusion vials |
| BNF code | 0502030A0AAAIAI |
| Virtual Therapeutic Moiety | Amphotericin B liposomal |
| Basis of preferred name | Other |
| Date of name applicability | 15 Jan 2020 |
| Previous name | Amphotericin B liposomal 50mg powder for solution for infusion vials |
| Basis of previous name | Other |
| Prescribing status | Caution - AMP level prescribing advised |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Amphotericin B liposomal |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 50.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | dispersioninfusion.intravenous |
| Dose Form | |
| Formulation | Powder for dispersion for infusion |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| AmBisome Liposomal 50mg powder for dispersion for infusion vials (Gilead Sciences Ltd) | |
| Virtual Medicinal Product Packs | |
| Amphotericin B liposomal 50mg powder for dispersion for infusion vials 10 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.